SAN FRANCISCO — Midi Health, a virtual care clinic making expert care accessible and affordable for all women experiencing the hormonal changes of midlife, has completed a $14 million seed investment co-led by Felicis and SemperVirens. Additional investment comes from leading women’s health investors including Emerson Collective, Icon Ventures, Operator Collective, Muse Capital, Steel Sky Ventures and Anne and Susan Wojcicki. Currently providing insurance covered care for patients in California, Midi will leverage the new capital to expand operations nationwide and launch partnerships with some of the largest hospital systems in the country, as well as major U.S. employers.
Hormonal changes through the menopause transition cause life-altering symptoms for 57 million American women, yet 75% of those who seek care don’t get the advice and treatment they need. Many women struggle to find any support at all due to a worsening shortage of OB/GYNs and lack of even the most basic menopause training across all specialties.
Midi closes this midlife care gap with virtual care guided by nationally recognized physicians and researchers who oversee a network of nurse practitioners trained in women’s midlife health. Midi offers evidence-based interventions ranging from lifestyle coaching and supplements to prescription medications, all covered by major insurance providers, including Aetna, Anthem Blue Cross, Blue Shield, Cigna, Health Net and UnitedHealthcare.
“There’s a huge unmet need in our healthcare system for women at this stage in life. Many practitioners lack the training to manage menopausal symptoms and specialists have nine to 12-month waiting lists,” said Joanna Strober, CEO and co-founder of Midi Health. “We provide access to the most skilled professionals in female health”.
Midi’s funding news coincides with the addition of several clinical hires with national prominence: Chief Clinical Officer Mindy Goldman, MD, who has practiced as an OB/GYN at UCSF for three decades and served as the Director of the UCSF Gynecology Center for Cancer Survivors and At-Risk Women; and National Medical Director Heather Hirsch, MD MS NCMP, former lead physician at the Menopause and Midlife Clinic at Brigham and Women’s Hospital, the second largest teaching hospital of Harvard Medical School. They join Chief Medical Officer and Midi co-founder Kathleen Jordan, MD, former SVP of Tia women’s health clinics, in guiding Midi’s protocols, clinician training, and integration with hospital systems.
